Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Survival Trends for Cancer Generally Increasing Worldwide
WEDNESDAY, Jan. 31, 2018 (HealthDay News) — Worldwide, survival trends for cancer are generally increasing, although there is considerable global variation in survival rates, according to a study published online Jan. 30 in The Lancet.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Regulators Trying to Reduce Physician Burden Linked to EHR
MONDAY, Jan. 29, 2018 (HealthDay News) — The Office of the National Coordinator for Health Information Technology (ONC) is trying to address some of the issues relating to physician electronic health record (EHR) burden, partly with the appointment of Don Rucker, M.D., who is skilled in informatics and board-certified in emergency and internal medicine, according to an article published in Medical Economics.
Health Care Spending Up, Mainly Due to Rising Prices
MONDAY, Jan. 29, 2018 (HealthDay News) — Americans under age 65 years who were insured through their employer spent more than ever before on health care in 2016, with faster spending growth in 2016 than in recent years, according to the Health Care Cost Institute (HCCI)’s annual Health Care Cost and Utilization Report.
Eyelid Squamous Cell Carcinoma Rate Increasing in England
WEDNESDAY, Jan. 24, 2018 (HealthDay News) — The incidence of squamous cell carcinoma (SCC) affecting the eyelids is rising in England, according to a study published online Jan. 23 in the British Journal of Ophthalmology.
Out-of-Pocket Expenditures Down With ACA Implementation
TUESDAY, Jan. 23, 2018 (HealthDay News) — Implementation of the Affordable Care Act (ACA) was associated with reduced out-of-pocket spending, although increases were noted in mean premium spending, according to a study published online Jan. 22 in JAMA Internal Medicine.
Diabetes Tied to Higher Rates of Serious Infection
TUESDAY, Jan. 23, 2018 (HealthDay News) — Patients with diabetes, particularly type 1 diabetes mellitus (T1DM), are at increased risk of serious infection, according to a study published online Jan. 12 in Diabetes Care.
Carboxytherapy, Platelet-Rich Plasma Similar for Stretch Marks
MONDAY, Jan. 22, 2018 (HealthDay News) — Both carboxytherapy and platelet-rich plasma (PRP) are safe and effective for the treatment of stretch marks, with no significant difference between the two methods, according to a study published online Jan. 7 in the Journal of Cosmetic Dermatology.
Full Text (subscription or payment may be required)
Guidelines of Care Developed for Skin Cancer Management
MONDAY, Jan. 22, 2018 (HealthDay News) — Guidelines of care have been developed for the management of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to two reports published online Jan. 10 in the Journal of the American Academy of Dermatology.
Abstract/Full Text – BCC (subscription or payment may be required)
Abstract/Full Text – cSCC (subscription or payment may be required)
Professionals Disagree About Asking Patients About Sexuality
THURSDAY, Jan. 18, 2018 (HealthDay News) — National Health Service (NHS) England recently recommended that professionals ask all patients their sexual orientation at every opportunity, although opinions are divided on whether this is appropriate, according to an article published online Jan. 17 in The BMJ.
Psoriasis Remission Described After Hepatitis C Virus Treatment
WEDNESDAY, Jan. 17, 2018 (HealthDay News) — A case of remission of psoriasis after treatment of chronic hepatitis C virus (HCV) has been described in a research letter published online Jan. 16 in the Annals of Internal Medicine.
High Response of Desmoplastic Melanomas to PD-1 Blockade
WEDNESDAY, Jan. 17, 2018 (HealthDay News) — Patients with desmoplastic melanoma have a high level of objective tumor response to treatment with antibodies to block programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1), according to a study published online Jan. 10 in Nature.
Ceramide-Infused Skin Barrier Cuts Stoma-Related Costs
FRIDAY, Jan. 12, 2018 (HealthDay News) — Use of a ceramide-infused ostomy skin barrier is associated with reduced stoma-related cost of care, according to a study published in the January/February issue of the Journal of Wound, Ostomy and Continence Nursing.
Ultrasound, Diluted Calcium Hydroxylapatite Improves Lines
FRIDAY, Jan. 12, 2018 (HealthDay News) — Microfocused ultrasound with visualization (MFU-V) and diluted calcium hydroxylapatite (CaHA) improves moderate-to-severe lines on the neck and/or décolletage, according to a study published online Dec. 29 in the Journal of Cosmetic Dermatology.
Full Text (subscription or payment may be required)
AMA Online Tools Address Systems-Level Physician Burnout
THURSDAY, Jan. 11, 2018 (HealthDay News) — Tools and resources have been developed to help address physician burnout at the systems level, which may affect more than half of doctors, according to a report published by the American Medical Association (AMA).
Psoriasis Is Independent Risk Factor for Comorbidity in Children
THURSDAY, Jan. 11, 2018 (HealthDay News) — Children with psoriasis have an increased risk of comorbidities compared to children without psoriasis, independent of obesity, according to a study published online Jan. 10 in JAMA Dermatology.
Economic Impact of Physicians Quantified for 2015
WEDNESDAY, Jan. 10, 2018 (HealthDay News) — Physicians have a large economic impact across the nation, creating an aggregate of $2.3 trillion of economic activity and supporting employment of nearly 12.6 million Americans, according to a report published by the American Medical Association.
Long-Term Night Shift Work Linked to Cancer Risk in Women
TUESDAY, Jan. 9, 2018 (HealthDay News) — There is a positive association between long-term night shift work and the risk of several common cancers for women, with evidence of a dose-response correlation, according to a study published online Jan. 8 in Cancer Epidemiology, Biomarkers & Prevention.
Hydrochlorothiazide May Up Basal, Squamous Cell Cancer Risk
FRIDAY, Jan. 5, 2018 (HealthDay News) — Hydrochlorothiazide use is associated with an increased risk of non-melanoma skin cancer (NMSC), with evidence of a dose-response relationship, according to a study published online Dec. 3 in the Journal of the American Academy of Dermatology.
Physicians Frequently Continue to Work While Ill
FRIDAY, Jan. 5, 2018 (HealthDay News) — Many physicians continue working and caring for patients while they are sick, according to an article published in Medical Economics.
Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
FRIDAY, Jan. 5, 2018 (HealthDay News) — Fluorouracil application can reduce the risk of surgery for squamous cell carcinoma for one year among patients with a history of keratinocyte carcinomas, according to a study published online Jan. 3 in JAMA Dermatology.
For Hospitals, No Benefit for Early Adoption of Financial Incentives
FRIDAY, Jan. 5, 2018 (HealthDay News) — Hospitals that volunteered to be under financial incentives for more than a decade as part of the Premier Hospital Quality Incentive Demonstration (early adopters) do not have better process scores or lower mortality than hospitals where these incentives were implemented later under the Hospital Value-Based Purchasing program (late adopters), according to a study published online Jan. 4 in The BMJ.
Certain Stresses, Burnout Causing Some Women to Leave Medicine
THURSDAY, Jan. 4, 2018 (HealthDay News) — Though equal numbers of men and women are now entering medical schools, the majority of physicians are still male, and female physicians face several unique stressors, according to a report published online in Medical Economics.
Immune-Related Adverse Events Up With Checkpoint Inhibitors
THURSDAY, Jan. 4, 2018 (HealthDay News) — Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease, immune-related adverse events (irAEs), or both, events can often be managed without discontinuing CPIs, according to a review published online Jan. 2 in the Annals of Internal Medicine.
Editorial (subscription or payment may be required)
Uterine Leiomyomas, Centrifugal Cicatricial Alopecia May Be Linked
WEDNESDAY, Jan. 3, 2018 (HealthDay News) — Black women with central centrifugal cicatricial alopecia (CCCA) have increased likelihood of uterine leiomyomas (ULs), according to a research letter published online Dec. 27 in JAMA Dermatology.
Higher Risk of Musculoskeletal Disorders in Some Physicians
WEDNESDAY, Jan. 3, 2018 (HealthDay News) — The prevalence of work-related musculoskeletal disorders (MSDs) appears to be high for at-risk physicians, according to a review published online Dec. 27 in JAMA Surgery.
Laser Improves QOL for Breast Telangiectasia Due to Radiation
TUESDAY, Jan. 2, 2018 (HealthDay News) — Laser monotherapy improves health-related quality of life (HR-QOL) in female patients with radiation-induced breast telangiectasias (RIBT), according to a study published online Dec. 20 in Lasers in Surgery and Medicine.
Full Text (subscription or payment may be required)
Copyright © 2018 ScoutNews, LLC. All rights reserved.
